We are live on
!
Find out more
Coherus Oncology
CHRS
CHRS
127 hedge funds and large institutions have $72.8M invested in Coherus Oncology in 2025 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
862% more call options, than puts
Call options by funds: $558K | Put options by funds: $58K
213% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 8
18% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 33
11% more funds holding
Funds holding: 114 → 127 (+13)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less capital invested
Capital invested by funds: $84.6M → $72.8M (-$11.8M)
24.06% less ownership
Funds ownership: 66.51% → 42.46% (-24%)
Holders
127
Holders Change
+13
Holders Change %
+11.4%
% of All Funds
1.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
25
Increased
39
Reduced
33
Closed
8
Calls
$558K
Puts
$58K
Net Calls
+$500K
Net Calls Change
-$191K
Top Buyers
| 1 |
Millennium Management
New York
|
+$962K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$696K |
| 3 |
Two Sigma Investments
New York
|
+$682K |
| 4 |
Jane Street
New York
|
+$573K |
| 5 |
Two Sigma Advisers
New York
|
+$430K |
Top Sellers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$3.46M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$1.48M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$483K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$481K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$426K |
